Agilon Health

Agilon Health, Inc. is a healthcare company, enables primary care physicians (PCPs) to be agents in the communities they serve. It provides healthcare for seniors across communities throughout the United States and has created an agilon Platform, which is a Total Care Model for community-based physicians. The firm serves a Total Care Model which focuses exclusively on Medicare and manages the comprehensive healthcare needs of its members through subscription-like member per month arrangements with health plans or directly with the Centers for Medicare and Medicaid services. The company was founded in 2016 and is headquartered in Austin, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Agilon Health reports strong 2022 performance and optimistic growth outlook

Agilon Health had a successful 2022, with strong financial performance and a focus on transforming healthcare through empowering primary care doctors. The company is optimistic about future growth, managing challenges in margins and financial management while leveraging opportunities in partnerships and operational efficiency.

Agilon Health triples Q1 earnings, eyes growth through partnerships

Agilon Health (AGL) delivered robust Q1 2023 results, maintaining outlook and confidence in clinical programs for high-cost patients and new partnerships.
Effective management of costs and revenues, alongside strategic acquisitions and partnerships, underpin the company's growth trajectory.
Challenges include margin impacts from external factors and managing costs associated with market expansion, balanced by opportunities in network growth and market transition.
The company's performance, strengths, challenges, and opportunities collectively shape its strategic direction towards sustained growth and operational excellence.

Agilon Health excels in Q2 2023, eyes growth opportunities

Agilon Health's strong financial performance in Q2 2023 underscores its operational excellence and growth potential. While challenges like revenue projections and medical margin variations exist, the company's strategic focus on risk adjustment and payer partnerships presents significant opportunities for future success.

Agilon Health reports strong Q3 performance, eyes growth opportunities

Agilon Health's Q3 2023 performance reflects robust growth in partner markets and revenue, supported by a unique model driving clinical and financial success.
While facing challenges in cash flow and benefit pullbacks, the company is well-positioned to leverage opportunities for growth and operational enhancement in '24.
Strategic decisions like selling the Hawaii business and focusing on core markets demonstrate a commitment to sustainable growth and operational efficiency.

Agilon Health addresses challenges, focuses on growth opportunities in 2024

Agilon Health faces challenges with medical margins but is making progress on their 2024 performance action plan to drive improvement.
The company is focusing on data visibility, quality partnerships, and efficiency gains to navigate the dynamic utilization environment and achieve growth.
Despite higher cash burn in 2024, Agilon anticipates positive cash flow from 2025 onwards if they meet their guidance and address payer negotiations.
Opportunities lie in a measured growth approach, cohort progression, and tuning payer arrangements to reflect the value provided by Agilon's services.

Agilon Health reports strong Q1 growth, navigates healthcare challenges

Agilon Health's Q1 '24 performance showcased growth in membership, revenue, medical margin, and adjusted EBITDA, despite challenges in cost trends and utilization.
The company's strategic focus on value-based care partnerships, data analytics, and operational efficiency positions them well for future growth and profitability.
While facing challenges in cost management and contract negotiations, Agilon Health is actively pursuing opportunities in sustainable payer contracts, technology enhancements, and benefit expansions.

Agilon Health reports strong Q2 performance and strategic growth outlook

Agilon Health's Q2 2024 earnings call reflects robust performance, operational strengths, strategic challenges, and growth opportunities in the evolving healthcare landscape.
The company's focus on refining payer relationships, enhancing data visibility, and driving operational efficiency positions it well for sustained success and market expansion.
Despite facing financial challenges and navigating payer dynamics, Agilon Health's proactive approach to innovation and leadership changes signals a commitment to long-term growth and value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Agilon Health, Inc. engages in providing healthcare services. It also provides the technology, people, capital, process, and access to a peer network of primary care physicians. The company was founded by Ronald A. Williams and Veeral Desai in 2016 and is headquartered in Austin, TX.

Atlanta Braves Holdings Inc

AGL, AFLYY and BATRK have been added to the Zacks Rank #5 (Strong Sell) List on November 19, 2024.

New Strong Sell Stocks for November 19th

Asbury Automotive Group

A. O. Smith

AOS, AGL and ABG have been added to the Zacks Rank #5 (Strong Sell) List on November 13, 2024.

New Strong Sell Stocks for November 13th

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that its Accountable Care Organizations (ACOs) achieved $150 million in gross savings (13% gross savings rate), including $37 million savings to the Medicare Trust Fund, during the 2023 performance year of the ACO Realizing Equity, Access and Community Health (ACO REACH) model. agilon's eight REACH ACOs operate under full risk, and in.

agilon health Reports ACO REACH Model Results for 2023 Performance Year

agilon health, inc. (NYSE:AGL ) Q3 2024 Earnings Call Transcript November 7, 2024 4:30 PM ET Company Participants Leland Thomas - Senior Manager-Investor Relations Steven Sell - Chief Executive Officer Jeffrey Schwaneke - Chief Financial Officer Conference Call Participants Lisa Gill - JPMorgan Justin Lake - Wolfe Research Adam Ron - Bank of America George Hill - Deutsche Bank Sameer Patel - Evercore Ryan Langston - TD Cowen Stephen Baxter - Wells Fargo Andrew Mok - Barclays Jack Slevin - Jefferies Michael Ha - Baird Thomas Keller - RBC Daniel Grosslight - Citi Operator Good afternoon and thank you for joining the agilon health Third Quarter 2024 Earnings Conference Call.

agilon health, inc. (AGL) Q3 2024 Earnings Call Transcript

I initially rated agilon health, inc. as a “hold” due to its volatile financial results and uncertain future, but recent developments necessitate a downgrade to 'sell'. The company's stock plummeted 60.1% since my last article, driven by disappointing Q3 results and reduced guidance, despite revenue growth. Rising medical costs and expansion expenses have severely impacted profitability, with a significant increase in net loss and negative EBITDA.

agilon health Plunges On A Poor Prognosis (Rating Downgrade)

Although the revenue and EPS for Agilon (AGL) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Here's What Key Metrics Tell Us About Agilon (AGL) Q3 Earnings

Agilon Health (AGL) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.06 per share a year ago.

Agilon Health (AGL) Reports Q3 Loss, Lags Revenue Estimates

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the third quarter ended September 30, 2024. “Our full-risk model enables primary care physicians to deliver high-quality care to their senior patients. Our Q3 results show that our membership is growing across our 26 partnerships, and it also highlights why we are taking necessary actions to strengthen execution withi.

agilon health Reports Third Quarter 2024 Results

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 2024 Wolfe Research Healthcare Conference including a fireside chat presentation on Tuesday, November 19, at 2:20 PM Eastern Time. A simultaneous webcast for the event can be accessed by visiting the “Events & Presentations” section of agilon's Investor Relations website at https://investors.agilonhe.

agilon health to Participate at 2024 Wolfe Research Healthcare Conference

NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. (NYSE: AGL) on behalf of long-term stockholders following a class action complaint that was filed against Agilon on March 19, 2024 with Class Period (1) Agilon common stock purchases traceable to the April 2021 initial public offering of Agilon stock; (2) pursuant, or traceable, or both, to materials issued in connection with the Company's secondary public offering that occurred on or about May 16, 2023; and/or (3) common stock between April 15, 2021 and February 27, 2024. Our investigation concerns whether the board of directors of Agilon have breached their fiduciary duties to the company.

AGILON ALERT: Bragar Eagel & Squire, P.C. is Investigating Agilon Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the third quarter 2024 after the market closes on Thursday, November 7, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international.

agilon health Sets Date to Report Third Quarter 2024 Financial Results

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 2024 Wells Fargo Healthcare Conference, including a fireside chat presentation on Wednesday, September 4, at 3:00 PM Eastern Time. A simultaneous webcast for the event can be accessed by visiting the “Events & Presentations” section of agilon's Investor Relations website at https://investors.agilonhe.

agilon health to Participate at 2024 Wells Fargo Healthcare Conference

agilon hagilon healthealth shares dropped significantly after disappointing financial results, down 11.9% in two days. The company's revenue surged 38.7% year over year, but its net loss nearly doubled, and guidance for 2024 is mixed. Concerns include declining cash reserves, potential for further dilution, and uncertainty regarding share valuation.

agilon health: Interesting Business Model, But Volatile And Uncertain

Magilon health, inc. (NYSE:AGL ) Q2 2024 Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Leland Thomas - VP, IR Steven Sell - CEO Jeffrey Schwaneke - CFO Conference Call Participants Lisa Gill - JPMorgan Justin Lake - Wolfe Research Stephen Baxter - Wells Fargo Ryan Daniels - William Blair Elizabeth Anderson - Evercore ISI Adam Ron - Bank of America.

Magilon health, inc. (AGL) Q2 2024 Earnings Call Transcript

While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Agilon (AGL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Agilon Health (AGL) came out with a quarterly loss of $0.07 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.04 per share a year ago.

Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the second quarter ended June 30, 2024. "Our second quarter results were in-line with our guidance, and we are maintaining medical margin and Adjusted EBITDA guidance for the full year," said Steve Sell, chief executive officer. "We continue to make progress implementing our performance action plan which should contribute t.

agilon health Reports Second Quarter 2024 Results

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the second quarter 2024 after the market closes on Tuesday, August 6, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international pa.

agilon health Sets Date to Report Second Quarter 2024 Financial Results

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that after a comprehensive search Karthik Rao, M.D., who has served as agilon's interim chief medical officer (CMO) since February 2024, has been appointed to the permanent CMO role, effective immediately. He previously served as senior medical director and vice president, network performance, at the company. Prior to joining agi.

agilon health Appoints Karthik Rao, M.D., as Chief Medical Officer

Investors can contact the law firm at no cost to learn more about recovering their losses.

The Portnoy Law Firm Announces Investigation of agilon health, inc. (NYSE: AGL)

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Jeff Schwaneke, an experienced finance, operational and managed care executive and director on agilon's board, will join the Company as chief financial officer and executive vice president effective July 1, 2024. He will be a member of agilon's Executive Leadership team reporting to chief executive officer (CEO), Steve Sell.

agilon health Names Jeff Schwaneke New Chief Financial Officer

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 44th Annual William Blair Growth Stock Conference including a presentation on Wednesday, June 5, at 12:20 PM Eastern Time. A simultaneous webcast for the event can be accessed by visiting the “Events & Presentations” section of agilon's Investor Relations website at https://investors.agilonhealth.com.

agilon health to Participate at 44th Annual William Blair Growth Stock Conference

NEW YORK, NY / ACCESSWIRE / May 20, 2024 / If you suffered a loss on your agilon health, inc. (NYSE:AGL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/agilon-health-lawsuit-submission-form?prid=80693&wire=1 or contact Joseph E.

Shareholders that lost money on agilon health, inc.(AGL) should contact Levi & Korsinsky about pending Class Action - AGL

RADNOR, Pa. , May 19, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc.

Deadline in 1 Day: Kessler Topaz Meltzer & Check, LLP agilon health, inc. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors to Contact the Firm (AGL)

LOS ANGELES, CA / ACCESSWIRE / May 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. ("agilon" or "the Company") (NYSE:AGL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

News for Agilon Health Stock (AGL)